Fisher Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.2M | Sell |
737,084
-36,263
| -5% | -$1.04M | 0.01% | 311 |
|
|
2025
Q1 | $25.9M | Buy |
773,347
+214,060
| +38% | +$7.18M | 0.01% | 290 |
|
|
2024
Q4 | $28.6M | Buy |
559,287
+77,188
| +16% | +$3.95M | 0.01% | 295 |
|
|
2024
Q3 | $24.6M | Buy |
482,099
+37,429
| +8% | +$1.91M | 0.01% | 317 |
|
|
2024
Q2 | $19.9M | Buy |
444,670
+8,647
| +2% | +$387K | 0.01% | 338 |
|
|
2024
Q1 | $20.4M | Sell |
436,023
-5,272
| -1% | -$247K | 0.01% | 335 |
|
|
2023
Q4 | $15.7M | Buy |
441,295
+387,435
| +719% | +$13.8M | 0.01% | 360 |
|
|
2023
Q3 | $1.6M | Sell |
53,860
-14,411
| -21% | -$429K | ﹤0.01% | 666 |
|
|
2023
Q2 | $1.23M | Hold |
68,271
| – | – | ﹤0.01% | 735 |
|
|
2023
Q1 | $1.1M | Sell |
68,271
-8,653
| -11% | -$139K | ﹤0.01% | 765 |
|
|
2022
Q4 | $1.41M | Buy |
76,924
+23,568
| +44% | +$431K | ﹤0.01% | 710 |
|
|
2022
Q3 | $1.05M | Buy |
+53,356
| New | +$1.05M | ﹤0.01% | 658 |
|